Search results
George Goldsmith, the CEO of Compass Pathways — the first psilocybin company to trade publicly in the US — insists that he's not in the psychedelics business. "First and foremost, no mushrooms...
George Goldsmith. Chairman and Co-founder. George is an entrepreneur dedicated to bringing about positive change in society with particular focus on health and wellbeing. George’s early training and experience was a multi-disciplinary blending of cognitive psychology, clinical psychology and computer science.
Oct 25, 2022 · George Goldsmith, the co-founder and executive chairman of Compass, said the company’s patent strategy was necessary to ensure that psilocybin therapy would one day be available to people...
Mar 28, 2024 · LONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Board Chair and co-founder George Goldsmith and fellow co-founder Ekaterina Malievskaia have resigned their seats on ...
George Goldsmith On Building A $360 Million Business By Accelerating Patient Access To Innovation In Mental Health. by Alejandro Cremades. In a recent insightful interview, George Goldsmith, the visionary entrepreneur and founder of Compass Pathways, shared the rich tapestry of his life and career.
Nov 9, 2021 · George Goldsmith, CEO and Co-founder, COMPASS Pathways, said: “No one is untouched by the mental health crisis – everyone has a story. We urgently need options for people who are not helped by...
Dec 4, 2020 · Compass Pathways developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. CEO George Goldsmith says the key is using ...
